| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9928020 | Optometry - Journal of the American Optometric Association | 2005 | 9 Pages |
Abstract
Due to progress of chemotherapeutic medications, the number of patients who manifest choroidal metastases will continue to increase. It is essential for the practitioner to be able to recognize this disease process to prevent visual loss and institute referral for proper treatment for metastatic disease.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jennifer O.D., Andrew O.D.,